Searchable abstracts of presentations at key conferences in endocrinology

ea0010s37 | Endocrinology of bone diseases: recent clinical and basic developments | SFE2005

Understanding the molecular basis of adverse effects of bisphosphonate drugs in the treatment of bone diseases

Rogers M , Thompson K

Bisphosphonates are powerful inhibitors of bone resorption and have become blockbuster drugs in the treatment of metabolic bone diseases. Enormous progress has been made over the last few years in understanding exactly how bisphosphonate drugs act at the molecular level. After targeting bone and selective internalisation by osteoclasts, nitrogen-containing bisphosphonates potently inhibit FPP synthase. Inhibition of this enzyme disrupts the flux through the mevalonate pathway,...

ea0010p61 | Pituitary | SFE2005

Reproducibility of the growth hormone response to resistance exercise in humans

Gilbert K , Thompson D , Hall G , Stokes K

ObjectiveThere is large inter-individual variation in the growth hormone (GH) response to resistance exercise, but the intra-individual variation is unknown. This study aimed to determine the reproducibility of the GH response to a 30-min resistance exercise session.DesignFollowing local Ethics Committee approval, nine male participants were familiarised before completing three trials in a random order. Durin...